Glutathione metabolism in normal and cystinotic fibroblasts. 1987

J D Butler, and J D Key, and B F Hughes, and F Tietze, and D S Raiford, and G F Reed, and P M Brannon, and S P Spielberg, and J D Schulman
Section on Biochemical Genetics, National Institute of Child Health and Human Development, Bethesda, Maryland 20892.

Intracellular concentrations of glutathione and activities of the enzymes gamma-glutamylcysteine synthetase, glutathione synthetase, and gamma-glutamyl transpeptidase were measured in confluent cultured human fibroblasts cell lines from 14 normal cell lines and four cystinotic cell lines. gamma-Glutamyl transpeptidase had a wide range of variability while the glutathione synthetic enzymes, gamma-glutamylcysteine synthetase and glutathione synthetase, had narrower variations and also exhibited no apparent relationship to glutathione content. No differences in the activities of these enzymes were found between normal and cystinotic cells in confluent cell cultures. The activities of the above enzymes and the cell number and content of glutathione, cystine, DNA, and total protein in two normal and two cystinotic fibroblast cell lines were measured during growth. The following growth-dependency patterns were observed: (1) gamma-glutamylcysteine synthetase activity increased markedly in lag and early log phases in both normal and cystinotic cells and decreased rapidly to low confluent levels thereafter. (2) gamma-Glutamyl transpeptidase showed the same wide range of activity noted at confluency but activities decreased in the log phase of growth, a pattern also seen in cystinotic cells. (3) Glutathione synthetase activity remained relatively constant during growth of normal cells but exhibited a peak of activity during lag and early growth of cystinotic cells. (4) Comparative glutathione levels of normal and cystinotic cells were not significantly different and exhibited similar fluctuations with time. (5) The cystine content of normal and cystinotic cells unexpectedly rose to high levels in the lag phase, then decreased to 0.1 nmol 1/2 cystine/mg protein in normal cells and to 0.3 to 1.2 nmol 1/2 cystine/mg protein in cystinotic cells during the log phase. As confluency was approached, normal cell cystine remained at low levels while cystinotic cell cystine rose to characteristically high levels of 50- to 100-fold greater than normal cells at late confluency. These studies extend our understanding of the regulation of glutathione and cystine content in cultured fibroblasts and suggest that glutathione content is closely controlled throughout the cell cycle in the face of varying activities of its anabolic and catabolic enzymes.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003554 Cystinosis A metabolic disease characterized by the defective transport of CYSTINE across the lysosomal membrane due to mutation of a membrane protein cystinosin. This results in cystine accumulation and crystallization in the cells causing widespread tissue damage. In the KIDNEY, nephropathic cystinosis is a common cause of RENAL FANCONI SYNDROME. Cystine Diathesis,Cystine Disease,Cystine Storage Disease,Cystinoses,Cystinosin, Defect of,Cystinosis, Nephropathic,Lysosomal Cystine Transport Protein, Defect Of,Nephropathic Cystinosis,Cystine Diatheses,Cystine Diseases,Cystine Storage Diseases,Cystinoses, Nephropathic,Defect of Cystinosin,Diatheses, Cystine,Diathesis, Cystine,Nephropathic Cystinoses,Storage Disease, Cystine,Storage Diseases, Cystine
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005721 Glutamate-Cysteine Ligase One of the enzymes active in the gamma-glutamyl cycle. It catalyzes the synthesis of gamma-glutamylcysteine from glutamate and cysteine in the presence of ATP with the formation of ADP and orthophosphate. EC 6.3.2.2. gamma-Glutamyl-Cysteine Synthetase,Glutamylcysteine Synthetase,Glutamate Cysteine Ligase,Ligase, Glutamate-Cysteine,Synthetase, Glutamylcysteine,Synthetase, gamma-Glutamyl-Cysteine,gamma Glutamyl Cysteine Synthetase
D005723 gamma-Glutamyltransferase An enzyme, sometimes called GGT, with a key role in the synthesis and degradation of GLUTATHIONE; (GSH, a tripeptide that protects cells from many toxins). It catalyzes the transfer of the gamma-glutamyl moiety to an acceptor amino acid. GGTP,Glutamyl Transpeptidase,gammaglutamyltransferase,gamma-Glutamyl Transpeptidase,Transpeptidase, Glutamyl,Transpeptidase, gamma-Glutamyl,gamma Glutamyl Transpeptidase,gamma Glutamyltransferase
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D005981 Glutathione Synthase One of the enzymes active in the gamma-glutamyl cycle. It catalyzes the synthesis of glutathione from gamma-glutamylcysteine and glycine in the presence of ATP with the formation of ADP and orthophosphate. EC 6.3.2.3. Glutathione Synthetase,Synthase, Glutathione,Synthetase, Glutathione
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J D Butler, and J D Key, and B F Hughes, and F Tietze, and D S Raiford, and G F Reed, and P M Brannon, and S P Spielberg, and J D Schulman
January 1978, Life sciences,
J D Butler, and J D Key, and B F Hughes, and F Tietze, and D S Raiford, and G F Reed, and P M Brannon, and S P Spielberg, and J D Schulman
March 1972, Clinica chimica acta; international journal of clinical chemistry,
J D Butler, and J D Key, and B F Hughes, and F Tietze, and D S Raiford, and G F Reed, and P M Brannon, and S P Spielberg, and J D Schulman
December 1971, Clinica chimica acta; international journal of clinical chemistry,
J D Butler, and J D Key, and B F Hughes, and F Tietze, and D S Raiford, and G F Reed, and P M Brannon, and S P Spielberg, and J D Schulman
July 1976, The Journal of biological chemistry,
J D Butler, and J D Key, and B F Hughes, and F Tietze, and D S Raiford, and G F Reed, and P M Brannon, and S P Spielberg, and J D Schulman
July 1982, Proceedings of the National Academy of Sciences of the United States of America,
J D Butler, and J D Key, and B F Hughes, and F Tietze, and D S Raiford, and G F Reed, and P M Brannon, and S P Spielberg, and J D Schulman
August 1980, In vitro,
J D Butler, and J D Key, and B F Hughes, and F Tietze, and D S Raiford, and G F Reed, and P M Brannon, and S P Spielberg, and J D Schulman
February 1977, Clinica chimica acta; international journal of clinical chemistry,
J D Butler, and J D Key, and B F Hughes, and F Tietze, and D S Raiford, and G F Reed, and P M Brannon, and S P Spielberg, and J D Schulman
December 1981, The Biochemical journal,
J D Butler, and J D Key, and B F Hughes, and F Tietze, and D S Raiford, and G F Reed, and P M Brannon, and S P Spielberg, and J D Schulman
July 1981, Pediatric research,
J D Butler, and J D Key, and B F Hughes, and F Tietze, and D S Raiford, and G F Reed, and P M Brannon, and S P Spielberg, and J D Schulman
April 1974, The Journal of clinical investigation,
Copied contents to your clipboard!